For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Insulin Glargine | Patients with Type 2 Diabetes mellitus Insulin Glargine: 10 IU SC every 24 hours for 6 days | 0 | None | 0 | 12 | 9 | 12 | View |
| Insulin Degludec | Patients with Type 2 Diabetes mellitus Insulin Degludec: 10 IU SC every 24 hours for 6 days | 0 | None | 0 | 12 | 6 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Lower limb paresthesias | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mild hypoglycemia | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |